Zepbound vs. Wegovy Trial - Search News

Order byBest matchMost fresh

News

Zepbound beats Wegovy for weight loss

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide,

Continue reading

· 1d · on MSN

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

Zepbound trims more belly fat than Wegovy, study shows

1d

Mounjaro helps users lose more weight than Wegovy, new trial reveals

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

Pharmalittle: We’re reading about Trump drug-pricing plan, obesity drug trial data, and more

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results